| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Wynnefield Partners Small Cap Value LP I last filed a Form 4 in October 2024, as 10% Owner at LFCR. The filings on record cover 2 companies. From June 2019 to October 2024, the filings on record show 43 open-market purchases and 2 sales.
Our model assigns Wynnefield Partners Small Cap Value LP I a middling insider score of 65/100, based on 65 past trades. Over a 12-month horizon, 70.8% of those trades were profitable, with an average 12-month return of +7.3%.
At the last filing, the largest reported position was 2,607,433 shares of LFCR. Net of sales, the LFCR filings show accumulation of 1,798,416 shares.
Shares as reported in the last Form 4 for each company; the most recent is from October 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2023 | 10% Owner | Buy | 25,677 | $7.22 | $185,488.20 | +1.9% | -0.6% | +14.0% | ||
| Oct 13, 2023 | 10% Owner | Buy | 1,457 | $7.25 | $10,563.25 | +0.1% | -5.9% | +13.4% | ||
| Oct 3, 2023 | 10% Owner | Buy | 8,742 | $7.24 | $63,283.70 | +0.7% | -0.7% | +6.4% | ||
| Sep 8, 2023 | 10% Owner | Buy | 1,686 | $7.24 | $12,215.04 | +0.1% | -14.9% | +15.5% | ||
| Aug 31, 2023 | 10% Owner | Buy | 5,366 | $7.25 | $38,880.20 | +0.4% | -7.3% | +13.6% | ||
| Aug 18, 2023 | 10% Owner | Buy | 4,864 | $7.25 | $35,248.64 | +0.4% | -2.6% | +10.3% | ||
| Aug 15, 2023 | 10% Owner | Buy | 13,039 | $7.24 | $94,350.20 | +1.0% | +0.4% | +8.1% | ||
| Nov 25, 2022 | LFCR Lifecore Biomedical, Inc. \de\ | 10% Owner | Buy | 627,746 | $7.97 | $5,003,135.62 | +34.7% | -28.6% | -10.3% | |
| Oct 24, 2022 | LFCR Lifecore Biomedical, Inc. \de\ | 10% Owner | Buy | 250,000 | $8.09 | $2,022,500.00 | +13.1% | -17.0% | -10.3% | |
| Jul 13, 2022 | 10% Owner | Buy | 10,000 | $4.09 | $40,925.08 | +0.7% | +89.0% | +83.8% |